Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bandmann

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Molecular and Cellular Probes|December 1, 1994
Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's diseaseD C Rubinsztein, C S Hanlon, R M Irving, et al.
Neurology|October 29, 2003
Candidate gene studies in focal dystoniaD Sibbing, F Asmus, I R König, et al.
BMJ Open|August 8, 2020
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyThomas Payne, Matilde Sassani, Ellen Buckley, et al.
Annals of Neurology|August 26, 1998
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's DiseaseJ Vaughan, A Durr, J Tassin, et al.
Brain : a Journal of Neurology|June 11, 2005
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study GroupC Kamm, D G Healy, N P Quinn, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Molecular and Cellular Probes|December 1, 1994
Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's diseaseD C Rubinsztein, C S Hanlon, R M Irving, et al.
Neurology|October 29, 2003
Candidate gene studies in focal dystoniaD Sibbing, F Asmus, I R König, et al.
BMJ Open|August 8, 2020
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyThomas Payne, Matilde Sassani, Ellen Buckley, et al.
Annals of Neurology|August 26, 1998
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's DiseaseJ Vaughan, A Durr, J Tassin, et al.
Brain : a Journal of Neurology|June 11, 2005
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study GroupC Kamm, D G Healy, N P Quinn, et al.
Pageof 5